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 The discovery of microRNAs (miRNAs) and their abilities to regulate in vivo 
protein synthesis have led to growing interests in miRNA research.  Due to their 
functions on regulating cellular processes that are related to diseases such as cancer, 
miRNAs can potentially become a new class of diagnostic biomarkers and therapeutic 
agents.  Since early 2000, researchers have reported more than 1,000 human miRNAs.  
To facilitate high-throughput clinical studies, there are needs for more accurate and 
robust analytical methods to detect and quantitate miRNAs.  Matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been used 
mainly for proteomics research.  In the past two decades, MALDI-TOF MS has also been 
used in genomics research.  Specifically, MALDI-TOF MS has been used in the analysis 
of oligonucleotides, both DNA and RNA.  In this study, the use of MALDI-TOF MS to 
detect specific miRNA was optimized, and the applicability of tandem MALDI-
TOF/TOF to perform partial de novo sequencing was evaluated.  
The MALDI process requires a small organic compound, often known as 
“matrix”, which readily undergoes desorption on contact with UV laser and assists the 
ionization of analyte.  Therefore, an investigative study was designed to compare five 
commonly used MALDI matrix compounds for oligonucleotide analysis.  The selected 
matrix compounds includes 3-hydroxypicolinic acid (3-HPA), 2’,3’,4’-trihydroxy-
acetophenone (THAP), 6-aza-thiothymidine (6-ATT), 3,4-diaminobenzophenone 
(DABP) and 3-hydroxycoumarin (3-HC).  The goal is to identify which is the best matrix 
for supporting the MALDI process and the subsequent tandem MALDI-TOF/TOF 
measurements.  The 4700 Applied Biosystems Proteomics Analyzer was initially used to 
perform linear MALDI-TOF MS analysis of a selected microRNA standard (miR-124a).   
The initial results of our MS/MS measurements indicated higher signal intensity or ion 
count of the parent ion of miRNA is required to achieve sequencing.  For this reason, we 
embarked on a series of studies to increase the signal intensity, especially on the effects 
of various parameters that were related to the desorption of miRNA during the MALDI 
process.  The results indicated 3-HPA matrix has provided the highest signal intensity.   
Thus, 3-HPA was used to further optimize the MALDI-TOF MS measurements of 
miRNA.  Once the parameters of MALDI-TOF MS were optimized, the use of tandem 
MALDI-TOF/TOF MS to perform partial de novo sequencing of miRNA was evaluated.  
Following the acquisition of initial MS/MS spectra of miR-124a, the use of different 
collision-induced dissociation (CID) pressures and delayed times to induce the 
fragmentation of miR-124a parent ion were investigated.  It was determined that the 4700 
Proteomics Analyzer could have a limitation on measuring the singly-charged miR-124a 
parent ion (7,161 m/z).  This could be due to the current design and/or settings on the 
reflectron within the MALDI-TOF/TOF instrumentation were not suitable for measuring 
ions with high molecular masses.  To overcome this limitation, the doubly-charged miR-
124a parent ion (3,582 m/z) was selected as an alternative for performing the tandem 
MALDI-TOF/TOF MS measurements.  Both post-source decay (PSD) and CID in the 
positive ion mode were used.  
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CHAPTER I 
INTRODUCTION 
Mature microRNAs (miRNAs) are small ribonucleic acid molecules, usually 
composed of ~19-25 ribonucleotides that are responsible for the regulation of protein 
synthesis
1
.  miRNAs are found in a wide variety of plant and animal cells, serving as 
post-transcriptional regulators that bind to complementary sequences of the three prime 
untranslated regions (3’ UTRs) of target messenger RNA (mRNA).  miRNAs originate 
from miRNA genes found in introns or exons of protein and non-protein coding genes, 
containing their own miRNA gene promoter and regulatory units, which allow 
transcription to occur.  Within the nucleus, RNA polymerase II binds to the gene 
promoter and transcribes miRNA genes into primary miRNAs (pri-miRNAs).  The 
resulting pri-miRNA transcript has a hairpin loop structure that contains a specially-
modified 5’ cap and a poly(A) tail at the 3’ end.  Drosha-Pasha complex in the nucleus 
cleaves the pri-miRNA near the hairpin stem into a 70-90 nucleotide (nt) stem-loop 
called premature miRNA (pre-miRNA)
2
.  The pre-miRNA product is then exported by 
Exportin 5 into the cytoplasm, where it is further cleaved into a short miRNA duplex by 
RNase III Dicer.  One of strands in the miRNA duplex is rapidly degraded, leaving only a 
single-stranded mature miRNA.  The mature miRNA associates with the RNA-induced 
silencing complex (RISC) and targets the 3’ UTR of mRNAs by partial annealing.  The 
miRNA-RISC regulates protein synthesis by repressing the translation of mRNA or 
 2 
causes mRNA degradation
3
. 
microRNAs were first discovered while studying Caenorhabditis elegans through 
genetic analysis of developmental mutants.  It was observed that small RNAs were 
responsible for inhibiting the translation of lin-14 mRNA into LIN-14 protein within C. 
elegans during its developmental stage transition
4
.  Since the early 2000s, the study of 
microRNAs has gained a lot of interests for its applications in therapeutic treatments 
against human diseases such as cancer, diabetes and regulation of the nervous system, 
providing many models for the continuous study of these biomolecules.   In 2007, an 
investigation of cyclin G1 was found to be a target of miR-122a, microRNA frequently 
down-regulated in human hepatocellular carcinoma
5
.  miR-122a was shown to modulate 
cyclin G1 expression in HCC-derived cell lines.  miR-21 is shown to be over expressed in 
tumor tissues compared with the matched normal tissues and the suppression of miR-21 
by antisense oligonucleotides inhibits tumor cell growth
6
.  miRNAs function as 
suppressors/regulators during transcription to inhibit the production of proteins required 
for the life cycle of diseases.  The ideology of miRNA regulation of diseases promoted 
the drive to identify them.  A database was created for miRNAs that have been identified 
from several plant and animal species, most importantly the miRNAs from Homo 
sapiens.  The human genome may encode over 1,000 miRNAs, but only 940 miRNAs 
have been isolated to date
7
.  There are 940 miRNAs isolated from the human body, but 
only a few are associated with cancerous diseases of the brain.  Our study focuses on 
brain cancer miRNAs, which regulate the development of brain cancer cells.
 Nucleic acid research has attracted many researchers to develop methods for 
 3 
analyzing nucleic acids including various types of RNA.  These methods, in turn, have 
been applied to the study of miRNAs.  A problematic issue for the analysis of miRNA is 
the availability of sample.  Most methods usually require hundreds of micrograms of total 
RNA for sample preparations, while tissue-derived RNA that are obtained from a clinical 
biopsy sample may only yield nano- or pico- gram levels of sample
8
.  The most 
commonly used approaches for miRNA identification and quantification include reverse 
transcriptase-polymerase chain reaction (RT-PCR) and microarray-based methods.  A 
novel miRNA quantitation method has been developed using stem-loop primer for 
reverse transcription and followed by TaqMan PCR analysis to achieve a precise 
quantification of specific miRNA in 25 pg of total RNA, which enables fast, accurate and 
sensitive miRNA expression profiling and can identify and monitor potential biomarkers 
specific to tissues or diseases
9
.  A novel miRNA profiling microarray was reported, in 
which miRNAs were directly labeled at the 3’ terminus with biotin and hybridized with 
complementary oligo-DNA probes immobilized on glass slides, and subsequently 
detected by measuring fluorescence of quantum dots that have been conjugated to 
streptavidin molecule, which is bound to miRNAs through streptavidin-biotin 
interaction
10
.  These reported procedures allow for low miRNA detection limits, but 
requires extensive preparations and resources.  To further improve the accuracy for 
miRNA analysis, the research work in this thesis has focused on using matrix-assisted 
laser desorption/ionization mass spectrometry (MALDI MS) to identify and sequence 
specific miRNA biomarkers.   
 4 
Although many RNA analytical methods exist in the literature there is minimal 
focus towards miRNA analysis by using MALDI MS.  In a recent publication by Barnes 
and Chiu
11
, a method was developed for the analysis of carcinogenic DNA adducts using 
MALDI MS.  This provided an in-sight for miRNA sample preparations and analysis 
using MALDI MS, due to the structural similarities of DNA and RNA.  MALDI tandem 
time-of-flight (TOF) MS has been used to detect and sequence 4-mer RNA sequences
12
.  
Several 4-mers with different sequences were used in that study.  The 4-mers were 
fragmented into single nucleotides and provided spectral data for sequence analysis.  This 
study showed that short RNA sequences could be detected and sequenced through the 
MALDI MS, providing the possibility to explore and use MALDI MS to detect and 
sequence larger RNA molecules such as miRNAs.  The focus of our research is to 
provide a method for the analysis and partial sequencing of pure synthetic miRNA using 
MALDI-TOF MS/MS, with a long-term goal to characterize specific miRNAs in 
biological samples. 
 Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) is an analytical technique for determining the mass-to-charge (m/z) 
ratio of an analyte through a process of creating molecular ions of the analyte and uses 
the m/z ratio to generate spectral data for identifying the analyte.  MALDI is the initial 
process that is crucial for generating sufficient ions for analysis.  This process requires a 
matrix compound that is compatible with the analyte.  The matrix compound must absorb 
UV laser readily for generating sufficient molecular ions.  The generated analyte ions are 
then drawn into the time-of-flight mass analyzer, in which the ions are separated by m/z 
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ratios.  The linear ion detector is used for MALDI-TOF MS, where ions travel in a linear 
path to the detector and generate the signals in the corresponding mass spectrum.  The 
linear MS process can be carried out further to perform the fragmentation of parent ion, 
through MALDI-TOF MS/MS. 
 
 
Figure 1.  Schematic diagram of 4700 Applied Biosystems Proteomics Analyzer. 
 
 MALDI-TOF/TOF MS/MS is based on collision-induced dissociation (CID).  In 
this study, MS/MS is used to determine the RNA sequence that makes up the primary 
structure of miRNA.  Through the MS/MS process, the parent ions that were generated in 
linear MS mode are selected by specifying a mass window to isolate the parent ion for 
CID fragmentation.  The parent ion is isolated in a collision cell where fragmentation is 
taken place.  Once inside the collision cell, with the higher gas pressure, the parent ions 
are bombarded with gas molecules.  The collision of gas molecules with the parent ions 
induces ion fragmentation.  The CID fragments are subjected to the second time-of-flight 
mass analyzer, where fragment ions are resolved.  Fragments containing more kinetic 
 6 
energy travel faster and penetrate further into the grid of increasing opposite potential in 
the reflectron, while fragments with less kinetic energy travel slower and shorter distance 
in the reflectron.  The difference in travel distance allows for compensation in difference 
in kinetic energies.  The fragment ions are then reflected towards the reflectron ion 
detector.  The spectrum generated from CID fragmentation can be used to determine the 
sequence of miRNA analyte. 
 The focus of our research group is towards the analysis of miRNAs.  Therefore, 
synthetic RNA oligonucleotide was used as a control to build a foundation for our long 
term goal.  Fortunately, our departmental facilities include a MALDI-TOF/TOF MS 
(4700 Applied Biosystems Proteomics Analyzer), which is equipped with laser energy to 
analyze and fragment RNA oligonucleotides for potential sequencing.  MALDI-TOF MS 
has been used to analyze and sequence shorter RNA oligonucleotides, but for our 
research we focus on relative long RNA that has at least 19 ribonucleotides.  The analysis 
of such a larger biomolecule requires the evaluation and/or development of new and 
robust analytical method for using MALDI-TOF MS.  In addition, our task has also 
included the partial sequencing of miRNA molecule. 
 7 
CHAPTER II 
EXPERIMENTAL METHODS AND MATERIALS 
A list of five matrix compounds, commonly used for oligonucleotide analysis 
through literature search, was compiled for matrix comparison study (Table 1).  For 
MALDI mass spectrometry of DNA, 3-HPA is one of the most commonly used MALDI 
matrices reported in a study of carcinogenic DNA adducts
11
.  A mixture of 2’,4’,6’-
trihydroxyacetophenone, 2’,3’,4’-trihydroxyacetophenone and ammonium citrate with 
molar ratios of 2:1:1 serves as a good matrix for the detection of DNA was reported
13
.  In 
2006, a new matrix of 3,4-diaminobenzophenone was demonstrated to be advantageous 
in the analysis of oligonucleotides by MALDI-TOF MS
14,
 
15
. 3-hydroxycoumarin was 
designed, synthesized, and tested as a matrix for MALDI-TOF MS analyses of a variety 
of synthetic oligodeoxynucleotides ranging from 3-70 bases
16
.  6-aza-2-thiothymine 
matrix and dibasic ammonium citrate were mixed with a montmorillonite catalyst for 
direct MALDI-MS analyses of synthesized oligonucleotides
17,
 
18
. 
Table 1. Five commonly used matrix compounds in oligonucleotide analysis.
Matrix Compound Reference
3-hydroxy picolinic acid (3-HPA) Subbi, J
Barnes, C
Kim, Y
Fu, Y
2',3',4'-trihydroxyacetophenone (THAP) Andersen, T
Zhu, Y
Fu, Y
3,4-diaminobenzophenone (DABP) Fu, Y
Xu, S
3-hydroxycoumarin (3-HC) Zhang, Z
6-aza-2 thiothymine (6-ATT) Zagorevskii, D
Song, F  
Preparation of matrix solutions 
All matrix compounds: 3-hydroxypicolinic acid (3-HPA), 2’,3’,4’-
trihydroxyacetophenone (THAP), 3,4-diaminobenzophenone (DABP), 3-hydroxy 
coumarin (3-HC) and 6-aza-2-thiothymine (6-ATT) were purchased from Sigma-Aldrich.  
Ammonium citrate dibasic ≥99.0% was purchased from Fluka.  The solvents used was 
acetonitrile (ACN), HPLC grade, was purchased from Fisher Scientific and anhydrous 
N,N-dimethylformamide (DMF) 99.8% was purchased from Sigma-Aldrich.  50% DMF 
was prepared using 500 µL of N,N-dimethylformamide and 500 µL of autoclaved 
deionized water.  10% and 50% ACN were prepared using ACN and autoclaved 
deionized water.  0.25 M 3-HPA matrix solution was prepared by dissolving 35.0 mg of 
3-HPA in 1 mL of 10% ACN with 8.80 mg (0.04 M) ammonium citrate dibasic.  To 
completely dissolve all 3-HPA, the mixture was vortexed for at least 1 min.  This was 
followed by filtering the 3-HPA solution with a 0.2 µm syringe filter.  
 9 
Preparation of miR-124a sample  
A pure, synthetic 22-mer RNA oligo (MW = 7,160.3 g/mol) containing 5’-
phosphate and 3’-hydroxyl was purchased from Integrated DNA Technologies, Inc..  The 
miRNA sample containing a total of 0.22 mg miR-124a was reconstituted in autoclaved, 
deionized water to 100 µM concentration.  Aliquots of miR-124a solution were obtained 
and diluted to the following concentrations, 5 µM, 10 µM, 20 µM and 50 µM. 
 
Thin- layer MALDI sample preparation method 
In this method, the sample was prepared by spotting 0.3 µL droplet of matrix 
solution onto a cleaned and dried stainless steel MALDI sample plate.  The matrix was 
allowed to air dry into thin-layer.  A 0.3 µL droplet of miR-124a sample is then spotted 
onto top of the dried matrix and allowed to air dry. 
 
Dried droplet MALDI sample preparation method 
In this method, a premixed sample was prepared by mixing 2 µL of matrix 
solution and 2 µL of miR-124a sample.  A 0.3 µL droplet of the premixed sample is then 
spotted onto a cleaned and dried stainless steel MALDI sample plate and allowed to air 
dry. 
 
MALDI-TOF MS measurements 
A MALDI-TOF/TOF instrument (4700 Proteomics Analyzer, Applied 
Biosystems, Framingham, MA) was used for all MS and MS/MS measurements.  The 
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4700 Proteomics Analyzer is equipped with a 355 nm Nd:YAG laser (200 Hz) and 4000 
Series Explorer Version 3.0 software.  Each sample was measured by using the linear 
high mass positive mode in the 4000 Series Explorer Version 3.0 software.  A focus mass 
of 7,161 m/z was used for the singly-charged miR-124a ion expected from each sample.  
Laser intensity at 7500 arbitrary units was used.  The accelerating voltage was +20.0 kV 
and grid voltage was +18.8 kV.  The instrument was equipped with a 200 Hz digitizer.  
The sampling bin size was 0.5 ns with an input bandwidth of 500 MHz, and a vertical full 
scale of 0.20 mV.  The linear detector voltage was +2.0 kV.  The pressure inside the 
entire instrument was maintained at the level of 10
-8
 Torr.  Each spectrum was 
automatically acquired by accumulating the results of 2500 shots (25 shots per sub-
spectrum) with random edge-biased positioning of each laser shot.  MALDI-TOF Linear 
MS was used to identify and confirm the presence of selected miRNA model in each 
sample before proceeding to MS/MS measurements. 
 
MALDI-TOF/TOF MS/MS measurements 
Each sample was measured using the MS-MS 1 kV positive mode in the 4000 
Series Explorer Version 3.0 software.  The precursor mass was the molecular mass of the 
miR-124a, and the mass window was -10.00 Da and +10.00 Da of the precursor mass.  
Molecular ions were extracted from the ion source after 460 ns delay time.  The 
suppressor for metastable ion was turned off.  The accelerating voltage at the ion source 
was at +8.0 kV, and grid voltage at +6.85 kV.  The collision cell was at +7.0 kV.  
Fragment ions were extracted from the collision cell after 68.8 ms delay time.  The 
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accelerating voltage from the collision cell was at +15.0 kV.  The sampling bin size was 
1.0 ns with an input bandwidth of 500 MHz, and a vertical full scale of 200 mV.  The 
reflector detector voltage was +2.1 kV.  The pressure inside the collision cell was 
adjusted with atmospheric air to the level of 10
-7
 Torr before the measurements were 
performed.  Each spectrum was automatically acquired by accumulating the results of 
2500 shot (25 shots per sub-spectrum) with random edge-biased positioning of each laser 
shot.  By using the Data Explorer Version 4.6 software, resulting mass spectrum was 
internally calibrated with the most abundant isotopic peaks of precursor ion.  Data 
Explorer was used to convert raw spectrum into centroid spectra to generate m/z peak list 
for sequence analysis.  The online Mongo Oligo Mass Calculator version 2.06 was used 
to calculate the average molecular mass of miR-124a.  In the case of singly charged 
positive ions, all phosphate groups are protonated plus the addition of an extra hydrogen 
proton for the positive charge.  Microsoft Office 2007 Excel software was used to 
generate the theoretical masses of expected CID fragments of miR-124a.  For post-source 
decay (PSD) measurements, the same parameter settings as the MS/MS measurements 
described above were used, except the collision cell was turned off and pressure was 
maintained at 10
-8
 Torr. 
The initial attempt to generate MS/MS spectra did not provide sufficient fragment 
ion signals.  In order to increase ion count and S/N ratio of fragment ions, optimization of 
linear MS measurements was systemically carried out.  The optimization of linear MS 
parameters may increase ion count and allow for more fragment ions to be produced 
during the CID process.  To increase the ion count and S/N ratio of [miR-124a + H
+
]
+
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ion, we investigated the following parameters: effects of laser intensity on measuring 3-
HPA matrix, effects of laser intensity on  measuring 20 µM of miR-124a, outcome from 
using higher concentrations of miR-124a, comparison of two different sample preparation 
methods, and investigation of using five different MALDI matrix compounds. 
 
Effects of laser intensity on measuring 3-HPA matrix 
Matrix solution containing 0.25 M 3-HPA, 0.04 M ammonium citrate dibasic was 
prepared in 10% ACN.  0.3 µL droplets of 3-HPA matrix solution were spotted onto 
MALDI sample plate, air-dried and analyzed using MALDI-TOF linear MS mode to 
acquire spectra at different laser intensities (5,000 – 7,900 arb. units). Low mass positive 
method was used to acquire each spectrum. 
 
Effects of laser intensity on measuring miR-124a 
Matrix solution containing 0.25 M 3-HPA, 0.04 M ammonium citrate dibasic was 
prepared in 10% ACN.  0.3 µL droplets of 3-HPA matrix solution were spotted onto 
MALDI sample plate, air-dried.  0.3 µL droplet of 20 µM miR-124a sample were spotted 
on top of a thin-layer 3-HPA matrix, air-dried and analyzed using MALDI-TOF linear 
MS mode to acquire spectra at different laser intensities (5,000 – 7,900 arb. units).  High 
mass positive method was used to acquire each spectrum. 
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Effects of increasing miR-124a concentration 
 miR-124a samples were prepared in concentrations of 5 µM, 10 µM, 20 µM, 50 
µM and 100 µM.  0.3 µL droplet of each sample were spotted on 0.25 M 3-HPA matrix 
thin-layer spots and analyzed using MALDI-TOF as described above, except the laser 
intensity was fixed at 7,500 arb. units. 
 
Thin-layer versus dried droplet sample preparation method 
 For the thin-layer method, 0.3 µL of 20 µM miR-124a sample was spotted on 
0.25 M 3-HPA matrix thin-layer spots.  For the dried droplets method, 2 µL of 20 µM 
miR-124a sample was premixed with 2 µL of 0.25 M 3-HPA matrix solution, vortexed to 
mix thoroughly.  0.3 µL droplet of the premixed solution was spotted on the MALDI 
sample plate and dried.  Both sample preparations of miR-124a was analyzed using 
MALDI-TOF linear MS mode with laser intensity at 7,500 arb. units. 
 
Hydrophobicity of matrix compounds 
ACDlabs 12.0 ChemSketch software was used to draw 3-D images of the five 
matrix compounds.  To estimate the hydrophobicity of each matrix compound, the same 
software was also used to calculate the log P value of each matrix compound. 
 
Solubility of matrix compounds  
An experimental study was designed for a direct comparison of the five matrix 
compounds.  The study was designed to maintain same 0.2 M matrix concentration, 
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solubilized in the same solvent, and contained the same amount of 0.04 M ammonium 
citrate dibasic.  The only variable component was the matrix compounds.  The solubility 
of the five matrix compounds were investigated in either 1 mL of 50% ACN or 50% 
DMF to obtain a target concentration of 0.2 M matrix solution.  For comparing the use of 
two solvents (50% ACN or 50% DMF), 0.2 M matrix solutions were prepared for each 
matrix compound.  MALDI matrix compounds were dissolved in 50% ACN or 50% 
DMF, both containing 0.04 M ammonium citrate dibasic, and determined maximum 
solubility of each matrix compound.  The amount of matrix solubilized in each of the 
solvents was recorded.  The results were compared to determine which was the best 
solvent, which yielded matrix concentrations nearest to 0.2 M. 
 
Drying time for selected matrix compounds 
A drying study was performed to determine the drying time of 0.3 µL droplet of 
each matrix solution that were prepared in 50% DMF and 0.04 M ammonium citrate 
dibasic solution. 0.3 µL droplets of each matrix solution were spotted on MALDI sample 
plate, allowed to air dry and the drying times were recorded. 
 
UV absorbance of selected matrix compounds 
Matrix solutions were prepared by dissolving 2.5 g of each matrix compound into 
1 mL of 10% ACN that contained 0.04 M ammonium citrate dibasic.  1.0 x 10
-5
 M matrix 
solutions were obtained through serial dilutions of each of matrix solution for UV 
absorbance measurements.  A Varian 50Bio Ultra Violet-Visible spectrophotometer 
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equipped with a quartz cuvette was used to acquire absorbance scan of each matrix 
solution.  10% ACN that contained 0.04 M ammonium citrate dibasic solution was used 
as the blank.  The parameters for absorbance scans were set accordingly; X mode: 600 
nm to 200 nm, Y mode: Abs and dual beam mode.  The scan controls were set to an 
average time of 0.0125 s, data interval of 0.20 nm and scan rate of 960.00 nm/min with 
baseline correction.  The extinction coefficient of each matrix was determined using the 
Beer’s-Lambert Law and absorbance values at 355 nm. 
 
Preparation of MALDI samples  
All matrix compounds (3-HPA, THAP, DABP, 6-ATT, 3-HC) were dissolved in 
50% DMF containing 0.2 M matrix and 0.04 M ammonium citrate dibasic, 0.3 µL 
droplets were spotted on MALDI sample plate.  Microscopic image of each spot was 
acquired by using a digital eyepiece camera mounted on an inverted microscope and 
equipped with an external light box to enhance visual clarity.  Visual images of thin-layer 
matrix spots and thin-layer matrix spots loaded with 0.3 µL droplets of 20 µM miR-124a 
sample were compared to observe the changes on each sample. 
 
“Spiking” experiment with 3-HPA matrix 
 A stock solution of 0.25 M 3-HPA matrix, 0.04 M ammonium citrate dibasic was 
prepared in 10% ACN.  A diluent solution containing 0.04 M ammonium citrate dibasic 
was also prepared in 10% ACN.  Starting with 0.25 M 3-HPA stock solution, stock 
solution was diluted with the diluent to obtain solutions containing 125,000 – 1953 µM 3-
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HPA matrix.   A stock solution of 100 µM miR-124a was used to prepare each “spiking” 
sample.  Equal volume of each diluted 3-HPA matrix solution was added to an equal 
volume of 100 µM miR-124a, to yield 50 µM miR-124a “spiked” samples.  The “spiked” 
samples are quickly spotted in 0.3 µL droplets onto MALDI sample plate for MALDI-
TOF MS analysis. 
CHAPTER III 
RESULTS AND DISCUSSION 
 The use of MALDI mass spectrometry to measure DNA has been more popular 
than RNA. Thus, there are limited number of reports on the topic of MALDI mass 
spectrometry of RNA, and even less for the analysis of miRNA.  In general, the basic 
molecular structures of DNA and RNA are similar to each other. However, the 2’-
hydroxyl group in each ribonucleotide has induced the formation of many unique 
secondary structures in different RNA molecules as well as changing the reactivity of 
RNA towards many chemical reactions. For these reasons, the analytical performance of 
MALDI mass spectrometry of RNA is not expected to be identical as in the case of 
measuring DNA. Based on the previous experience in our research group on using 
MALDI-TOF MS to measure DNA
11
, the most commonly used 3-HPA matrix could 
generate relatively strong signals from measuring small DNA oligos. For the purpose of 
carrying out the subsequent MS/MS measurements of miRNA, relative high signal 
intensity in linear MALDI-TOF MS measurements is required. This is because if more 
precursor miRNA ions will be available for undergoing the CID process, more fragment 
ions will be generated. Thus, the use of 3-HPA matrix in linear MALDI-TOF MS was 
examined at the beginning of this study. In an initial experiment, the standard 0.25 M 3-
HPA matrix, 0.04 M ammonium citrate dibasic and 20 µM miR-124a sample were 
spotted on the sample plate by using the thin-layer method, and analyzed with linear 
positive mode in MALDI-TOF MS.  The peak that corresponded to [miR-124a + H
+
]
+
 
(7161.3 m/z) was detected as shown in Figure 2, along with peak that corresponded to 
[miR-124a + 2H
+
]
2+
 (3581.1 m/z).  The singly-charged [miR-124a + H
+
]
+
  ion was 
detected at 7161.3 m/z due to the transfer of a proton (H
+
) from 3-HPA matrix to ionize 
miR-124a during the MALDI desorption/ionization process.  The doubly-charged [miR-
124a + 2H
+
]
2+
 ion was generated by transferring 2H
+
 from 3-HPA, and yielded a m/z 
value of 3581.1.  Na
+
 adduct peaks were also observed on the right-hand side of the 
singly and doubly-charged ion peaks, adding an additional 22 Da to [miR-124a + H
+
]
+
 
and 11 Da to [miR-124a + 2H
+
]
2+
.  3-HPA matrix cluster ions were found at below 300 
m/z (not shown), therefore did not interfere with the MALDI-TOF MS measurements of 
miR-124a precursor ions as observed in Figure 2, and allowing the correct selection of 
miR-124a precursor ions for MS/MS measurements.   
 
 
Figure 2.  MALDI mass spectrum of 20 µM miR-124a.  The theoretical mass of a singly-charged [miR-
124a + H
+
]
+
 ion is 7161.3 Da. 
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In 2006, Andersen and co-workers
12
 have studied the collision-induced 
dissociation of 4-mer RNA fragments by using tandem MALDI-TOF/TOF MS, and 
proposed a mechanism for the collision-induced dissociation of RNA molecule, in which 
the presence of a 2’-hydroxyl group in each ribonucleotide has favored the formation of 
c- and y-ions in comparison to (a-B)- and w-ions as in the case of DNA fragmentation.  
 
Figure 3. Schematic of possible fragmentation sites on RNA oligonucleotide structure.  c-y fragmentation 
is more favorable during RNA fragmentation. 
 
More recently, by using the technology of ion trap, McLuckey
19
 and his associates 
have confirmed the 2’-OH group on RNA significantly facilitates the production of c/y-
ions.  In order to minimize the base loss and internal fragmentation of RNA precursor 
ions, Breuker and her associates
20
 have adopted the use of collisional cooling of precursor 
ions and the selection of precursor ions of relatively low negative net charge.  In the case 
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of MALDI mass spectrometry, majority of precursor ions are singly charged as shown in 
Figure 2.  In comparison to molecular ions that carry multiple charges, the internal energy 
of singly charged ions are expected to be considerably lower.  For this reason, both base 
loss and internal fragmentation of precursor ion of miR-124a were not observed.  On the 
other hand, high CID energy (≥ 1 KeV) can be achieved when the molecular ions are 
extracted into the time-of-flight mass analyzer by using a potential difference as high as 
20 kilovolt.  As demonstrated in a recent paper from our research group, the high CID 
energy in tandem MALDI-TOF/TOF MS measurements of DNA adducts had induced 
more fragmentation of the precursor ion than using other MS/MS techniques.  In 
summary, MALDI-TOF/TOF MS has the advantage on minimizing base loss and internal 
fragmentation of RNA precursor ions at the initial stage of desorption/ionization process, 
and provides relatively high CID energy to induce RNA fragmentation in MS/MS 
measurements.  For these reasons, all experimental work in this thesis has focused on 
using MALDI-TOF/TOF as the primary MS technique. 
For initial MS/MS measurements, the singly charged [miR-124a + H
+
]
+
 ion was 
selected as precursor ion, because of its higher ion count and S/N ratio in comparison to  
the doubly-charged [miR-124a + 2H
+
]
2+
 ion.  The 7161.3 m/z peak was first identified in 
the linear mode.  The [miR-124a + H
+
]
+
 ion was selected by using a timed ion selector 
with a mass window of ±10 Da of the focus mass of the selected precursor ion.  Precursor 
ions were channeled through a collision cell at 10
-7
 Torr, where ions were bombard with 
atmospheric gas molecules and underwent fragmentation.  The fragment ions were then 
extracted into the second TOF analyzer where the ions were separated.  An initial 
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MS/MS spectra of 25 µM miR-124a was generated (Figure 4) providing peaks 
identifiable as precursor ions.  In Figure 4, the S/N ratio of the precursor ion was lower 
than expected partly due to the background noise level was relatively high.  There might 
be potential CID fragments in the MS/MS measurements, but signals were too low to be 
detected.  
 
 
Figure 4. Initial MS/MS spectrum of 25 µM miR-124a. Focus mass of 7161 m/z, mass window: ± 10 Da. 
 
In order to improve the signal intensity of each CID fragment, more precursor 
ions must undergo the CID process.  One of the approaches to ensure an increase on the 
number of precursor ions would be available for the CID process is to optimize the initial 
MALDI process.  Therefore, most of the remaining efforts in this research thesis focused 
on optimizing the desorption of RNA during the MALDI process. 
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Effects of laser intensity on measuring 3-HPA matrix 
 The protonated 3-HPA ion corresponded to 140.2 m/z peak in the spectrum Figure 
5a, along with peaks that corresponded to various matrix cluster ions.  We investigated 
MALDI process of 3-HPA matrix with increasing laser intensity from 5,000 – 7,900 arb. 
units to determine the optimal laser intensity to produce the highest amount of 3-HPA ion 
to support the desorption/ionization of selected miRNA analyte.  In Figure 5b, the ion 
count for the 3-HPA ion is at the lowest level when laser intensity of 5,000 – 6,000 arb. 
units were used.  The highest signal of 3-HPA was obtained with laser intensity of 7,000 
– 7,900 arb. units.  From this investigation, we determined that the optimal laser intensity 
for producing maximum number of 3-HPA ions is between 7,000 – 7,500 arb. units of 
laser intensity. 
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Figure 5. (a) MALDI mass spectrum of 3-HPA matrix, and (b) effects of laser intensity on signal-to-noise 
(S/N) ratio and ion count of 3-HPA matrix ion.  
 
a 
b 
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Effects of laser intensity on measuring miR-124a 
 3-HPA matrix and its cluster ions are shown in the MALDI-TOF linear MS 
spectrum below (Figure 6a), along with the [miR-124a + H
+
]
+
 ion species at 7161.9 m/z.  
From Fig 6a, the 3-HPA matrix ion peak is at the lower mass range as compared to the 
peak of [miR-124a + H
+
]
+
 ion.  The spectral resolution in Figure 6a can allow accurate 
identification of miR-124a and eliminates any chance of matrix interference.  We 
investigated the effects of increasing the laser intensity (5,000 – 7,900 arb. units) on S/N 
ratio and ion count of [miR-124a + H
+
]
+
 ion by using the linear positive ion mode in 
MALDI-TOF MS.  The S/N ratio and ion count of miR-124a signal were below the 
detectable level as shown in Figure 6b.  At laser intensity of 6,000 – 7,000 arb. units, 
there was minimal detection of [miR-124a + H
+
]
+
 ion.  The highest signal intensity was 
observed at laser intensity of 7,500 arb. units, while the signals began to drop at the 
maximum level of laser intensity.  The optimal S/N ratio and ion count for [miR-124a + 
H
+
]
+
 ion occurs at laser intensity 7500 and correlates with the investigation of using 
different laser intensity to desorb and ionize 3-HPA matrix. 
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Figure 6. (a) MALDI mass spectrum of 20 µM miR-124a, and (b) effects of laser intensity on signal-to-
noise (S/N) ratio and ion count of [miR-124a + H
+
]
+
 ion. 
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Effects of increasing miR-124a concentration 
Besides optimizing the laser intensity, another approach to increase to the signal 
intensity in any instrumental technique including MALDI mass spectrometry is to 
increase the concentration of analyte being measured. Thus, the effects of increasing the 
concentration of miR-124a to the MALDI-TOF MS measurements of miR-124a were 
investigated by using the optimal laser intensity. MALDI spectra were acquired by using 
various miR-124a concentrations as shown in Figure 7a. Surprisingly, the signals of 
[miR-124a + H
+
]
+
 ion at 7,161 m/z were decreased after reaching the maximum level 
around 10 µM (Figure 7b). By comparing the spectra with increasing miR-124a 
concentration, there is a noticeable increase in the peak intensity of Na
+
 adducts, i.e. miR-
124a + Na
+
 ion.  This was due to the fact that the miR-124a standard was not absolutely 
free of sodium salt and the amount of ammonium ions in the matrix solution for 
suppressing Na
+
 adduct was fixed.  Thus, with an increasing amount of miR-124a 
sample, more Na
+
 adducts were observed when the sample was measured by using 
MALDI-TOF MS. More importantly, this has lowered the signal intensity that 
corresponded to the [miR-124a + H
+
]
+
 ion as shown in Figure 7b.  Since the Na
+
 adducts 
would normally be excluded from the subsequent MS/MS measurements, the use of 
increasing concentration of miR-124a in the MALDI sample would not be beneficial.  
From Figure 7b, the optimal range of miR-124a concentration is 5 – 20 µM, with 10 µM 
yielding the maximum S/N ratio and ion count.   
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Figure 7. (a) MALDI mass spectra of miR-124a at different concentrations, and (b) effects of miRNA 
concentration on its corresponding signal-to-noise (S/N) ratio and ion count in MALDI-TOF MS 
measurements.  
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Thin-layer versus dried droplet method 
To determine which sample preparation method would provide better mass 
resolution, and S/N ratio for measuring miR-124a, two different MALDI sample 
preparation methods were compared.  From the mass spectrum that was obtained by 
using the thin-layer method (Figure 7a), minimal noise interference was observed and 
yielded strong signals for both [miR-124a + H
+
]
+
 and [miR-124a + 2H
+
]
2+
 ions.  
Whereas, the results obtained from using the dried droplet method (Figure 7b) have 
shown an increase in noise interference and only yielded a lower signal for [miR-124a + 
H
+
]
+
 ion.  The comparison of mass resolution and S/N ratio confirm that thin-layer 
sample preparation method yields higher signal intensity.  Premixing the RNA sample 
with 3-HPA matrix solution in the dried droplet method might lead to different rate of co-
crystallization of 3-HPA matrix with the RNA sample and resulting in less favorable 
crystal morphology, thus yielding a lower signal for miR-124a. 
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Figure 8. MALDI mass spectra of 20 µM miR-124a samples that were prepared by using (a) thin-layer 
method and (b) dried droplet method. 
 
Hydrophobicity of matrix compounds 
 Hydrophobicity can be considered as a measure of how insoluble a chemical 
compound is in water or polar solvent.  In Table 2, the 3-D molecular structure of each 
matrix compound is illustrated.  To evaluate the hydrophobicity of the selected MALDI 
matrix compounds, the log P value of each matrix compound was calculated.  By 
definition, P is the partition coefficient of a compound between two solutions, which is 
equivalent to the ratio of concentrations of the compound between the two solutions.  The 
a 
b 
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calculations of all log P values were carried out by using the ACDlabs 12.0 ChemSketch 
software.  A low log P value represents the compound is less hydrophobic or more 
soluble in water as well as weaker intermolecular interaction.  Whereas, a high log P 
value represents the compound is more hydrophobic or less soluble in water as well as 
stronger intermolecular interaction.  The log P values for 3-HPA (0.72 ± 0.36) and 6-
ATT (-0.42 ± 0.83, -1.46 ± 0.64) were lower than the other three matrix compounds, 
indicating 3-HPA and 6-ATT are most likely to be dissolved in polar solvents.  6-ATT 
contains two different log P values due to its ability to exist in two different states of 
electronic localization, transferring electrons from oxygen to sulfur atom.  THAP, 3-HC 
and DABP have comparatively high log P values, thus these compounds are expected to 
be less soluble in polar solvents.  Based on their log P values, the hydrophobicity of the 
selected matrix compounds can be ranked in the following order: 6-ATT < 3-HPA < 3-
HC < THAP < DABP.  As shown in Table 2, all five selected matrix compounds have 
shared similar aromatic ring structure.  Thus, their order of hydrophobicity is comparable 
to the increasing order of their molecular masses.  In other words, for the selected 
MALDI matrices, the hydrophobicity of the matrix compound is proportional to its 
molecular mass.  
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Table 2. 3-D structure  and Log P value of matrix compounds
Matrix Compound 3-D Structure Mass (g/mol) Log P Value
3-hydroxy picolinic acid 139.11 0.72 +/- 0.37
(3-HPA)
2',3',4'-trihydroxyacetophenone 168.15 1.73 +/- 0.37
(THAP)
3,4-diaminobenzophenone 212.25 2.19 +/- 0.43
(DABP)
3-hydroxycoumarin 162.14 1.60 +/- 0.76
(3-HC)
6-aza-2-thiothymine 143.17 -0.42 +/- 0.84
(6-ATT) -1.46 +/- 0.65
 
Solubility of selected matrix compounds 
Based on an in-depth literature study of the recent publications in which MALDI 
mass spectrometry was used to measure either DNA or RNA, the most commonly used 
MALDI matrix concentrations were between 0.1 M and 0.2 M. For the purpose of 
comparing the outcomes of using each individual matrix compound to measure miRNA, 
the same matrix concentration must be used.  Thus, the concentration of 0.2 M was 
chosen as a reference point in this study.  The reason for choosing a higher matrix 
concentration was to ensure the ratio of matrix to analyte in the final co-crystalline 
sample was as high as possible, which is one of the general requirements for successful 
MALDI mass spectroscopic measurements.  In other words, excessive matrix is needed to 
support the MALDI process.  The amount of matrix required to prepare 1 mL of 0.2 M 
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matrix solution was determined for each of the five matrix compounds (Table 3).  Using 
these values as reference, saturated matrix solutions were prepared for each of the matrix 
compounds using 50% ACN.  It was determined that 3-HPA was readily dissolved and 
reached 0.25 M.  Whereas, THAP, DABP and 6-ATT were less soluble and yielded 
concentrations of < 0.1 M.  For 3-HC, it was practically insoluble in 50% ACN.  Since 
0.2 M matrix solution was not achievable for 4 out of 5 matrix compounds, an alternative 
solvent was selected (50% DMF).  All five matrix compounds were readily dissolved in 
50% DMF, and 0.2 M of each individual matrix solution was prepared.  The reason for 
using only 50% DMF instead of 100% DMF was because 0.04 M of ammonium citrate 
dibasic was a required component in the matrix solution, which would not be soluble in 
100% DMF.  Normally, ammonium citrate dibasic is served as a desalting reagent in 
MALDI matrix, and is essential to MALDI mass spectrometry of nucleic acids. 
 
Table 3. Solubility of matrix compounds in 50% ACN:H2O and 50% DMF:H2O
Amount (mg) Amount Amount
Matrix [0.2 M] Dissolved (mg) Conc. (M) Dissolved (mg) Conc. (M)
3-HPA 27.82 35.0 0.25 27.8 0.20
THAP 33.63 10.2 0.06 33.6 0.20
DABP 42.45 2.2 0.01 47.3 0.22
3-HC 32.43 - - 32.5 0.20
6-ATT 28.63 11.8 0.08 28.3 0.20
50% ACN:H2O 50% DMF:H2O
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Drying time of selected matrix compounds 
It has been reported that the rate of drying the matrix-sample mixture on the 
MALDI sample plate is related to the outcome of MALDI mass spectroscopic 
measurements.  For this reason, one of the initial experiments in this study was to 
determine the drying time for selected matrix solutions.  In addition, it would become 
impractical to wait for a long time to dry a matrix-sample mixture before a measurement 
could be carried out.  In Table 4, all the drying time for 0.3 µL droplet of each matrix 
solution were recorded.  3-HPA matrix droplet was completely dried after 5 minutes at 
room temperature and pressure.  This was followed by 6-ATT at 10 minutes and 3-HC at 
20 minutes.  Both THAP and DABP matrix droplets were dried after one hour and more 
than two hours waiting, respectively.  Comparison of ascending drying time, the matrix 
compounds prepared in 50% DMF can be ranked in the following order: 3-HPA < 6-ATT 
< 3-HC < THAP < DABP.  Ideally, the drying time for a matrix droplet should not take 
longer than 5 minutes.  The prolonging of drying time can potentially jeopardize the 
matrix itself because MALDI matrix compounds are sensitive to light.  The drying time 
of the sample droplet must also be considered.  This is because the addition of the sample 
to the matrix solution will also extend the amount of time for drying the mixture before 
the measurement can be carried out.  Since other solvents, for example DMSO, might not 
be fully compatible with MALDI mass spectrometry, 50% DMF was considered to be the 
best solvent for dissolving the selected matrix compounds in this study.  
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Table 4. Drying time of 0.2 M matrix solutions prepared in 1 mL 50% DMF:H2O solvent
Matrix (mg) Matrix (ug) Drying Time
Matrix Compound in 1 mL [0.2 M] in 0.3 uL (minutes)
3-HPA 27.8 8.34 5
THAP 33.7 10.11 60
DABP 42.5 12.75 >2 hrs
3-HC 32.5 9.75 20
6-ATT 28.6 8.58 10  
UV absorbance of selected matrix compounds 
In order to determine which is the most important property of the selected matrix 
compounds for supporting the MALDI process, i.e. generation of molecular analyte ions, 
the UV absorbance of each matrix compound was measured.  To facilitate the MALDI 
process, the 4700 Applied Biosystems Proteomics analyzer that has been used in this 
study is equipped with a 355 nm Nd:YAG laser.  Other MALDI-TOF mass spectrometers 
may use a different source of laser, for example nitrogen laser (335 nm).  Therefore, 
instead of single wavelength measurements, UV scan of each matrix compound was 
performed.  The UV scans would also allow us to correlate the UV absorbance at 355 nm 
of each matrix compound to the production of both 3-HPA and miRNA molecular ions.   
In Figure 9, when comparing the absorbance at 355 nm, the higher absorbance of DABP 
at is due to the fact that higher concentration of DABP was used.  Otherwise, THAP and 
3-HC have comparable absorbance at 355 nm, and both 3-HPA and 6-ATT are 
undetectable.  This was due to the fact that all UV absorbance measurements had to be 
carried out at much lower concentrations than they were normally used in MALDI 
sample preparation.  Nevertheless, the results in Figure 9 do allow us to compare the 
absorptivity of selected matrix compounds for UV photons being used in the MALDI 
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process.  By using the Beer’s-Lambert law, the extinction coefficient of selected matrix 
compounds at 355 nm were calculated (Table 5).  In general, the higher the extinction 
coefficient, the higher the efficiency on absorbing the photon.  The extinction coefficients 
were not calculated for 3-HPA and 6-ATT because their absorbance at 355 nm were 
undetectable.  
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Figure 9. UV absorption spectra (200-600nm) of five different matrix compounds prepared in 10% 
ACN:H2O and 0.04 M ammonium citrate dibasic solution. 
 
Table 5. Extinction coefficient of matrices at 355 nm wavelength
Extinction Coefficient
Matrix Compound Concentration (M) Absorbance at 355 nm (cm
-1
 L mol
-1
)
3-HPA 1.80E-05 - -
THAP 1.55E-05 0.0201 1297
DABP 1.14E-05 0.0826 7246
3-HC 2.00E-05 0.0107 535
6-ATT 1.96E-05 - -  
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Co-crystallization of MALDI matrix with miR-124a 
Microscopic images of matrix spots and spots that contained both matrix and 
miR-124a were recorded in Table 6.  By comparing the images of matrix spots, it is 
obvious the physical and chemical properties of selected matrix compounds including 
their hydrophobicities are different from each other.  Therefore, the physical appearance 
of these images could indirectly confirm the calculations of log P values are reliable.  The 
appearance of 3-HPA, THAP, and DABP were significantly changed after the matrix was 
redissolved and co-crytallized with miR-124a.  Whereas, the physical appearance of 3-
HC and 6-ATT did not change much following the co-crystallization with miR-124a.  As 
documented in the literature by several other research groups, the co-crystallization 
process between MALDI matrix and analyte of interest is important to the success of 
MALDI mass spectroscopic measurements.  This is because the intermolecular 
interactions between MALDI matrix and analyte of interest within the matrix-sample co-
crystalline sample could directly affect the extent of matrix protection for the more 
fragile analyte molecules from laser irradiation as well as the subsequent desorption of 
analyte from the co-crystalline sample.  Another important observation that could be 
made from the images of the spots that contained both matrix and miR-124a was the 
distribution of co-crystals was uneven.  For example, in the case of 3-HPA, the co-
crystals clustered around the edge of the spot.  This information would be useful for 
searching the areas in which stronger signals could be obtained from the co-crystalline 
sample.  From Table 6, it has also been noted DABP and 6-ATT spots did not have 
uniform crystalline structure.  In the case of DABP, it might be the cause of negative 
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results from MALDI mass spectroscopic measurements (see below).  The uniformity in 
co-crystalline structure is expected to allow for better matrix-analyte interactions.  This 
study was based on physical observations only, therefore to confirm if crystal formation 
plays an important role in MALDI-MS measurements of miR-124a, MALDI-TOF MS 
analysis was required. 
 
Table 6. Photograph of dried matrix spots prepared in 50% DMF:H2O
Matrix Compound Matrix only Loaded with sample
3-hydroxy picolinic acid
(3-HPA)
2',3',4'-trihydroxyacetophenone
(THAP)
3,4-diaminobenzophenone
(DABP)
3-hydroxycoumarin
(3-HC)
6-aza-2-thiothymine
(6-ATT)
 
 MALDI-TOF MS analysis of miR-124a spotted on 3-HC and DABP matrix did 
not yield any signal that corresponded to [miR-124a + H
+
]
+
 ions.  Whereas, the use of 6-
ATT, THAP, or 3-HPA matrix all yielded detectable amount of [miR-124a + H
+
]
+
 ions as 
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shown in Figure 10.  From the spectra of using 6-ATT and THAP as matrix, relative low 
S/N ratios were obtained from the detection of miR-124a.  In the case of 3-HPA, the 
highest S/N ratio for [miR-124a + H
+
]
+
 ions was achieved.  Overall, MALDI-TOF MS 
analysis confirmed 3-HPA matrix as the best matrix to be used for miR-124a analysis.  
 
“Spiking” experiment with 3-HPA matrix 
After comparing the outcome from using the selected matrix compounds in the 
previous section, it was confirmed that 3-HPA matrix could generate the highest signals 
for MALDI-TOF mass spectrometry of miRNA.  A further investigation was conducted 
to optimize the use of 3-HPA matrix by using a modified sample preparation method 
referred as “spiking”.  This study was designed to determine if additional levels of 3-
HPA matrix spiked into miR-124a sample would help to increase S/N ratio and ion count 
of [miR-124a + H
+
]
+
 ion.  By using the conventional thin-layer sample preparation 
method i.e. no additional 3-HPA matrix, S/N ratio of 17 and ion count of 68 were 
obtained from measuring 50 µM of miR-124a.  As shown in Table 7, as the amount of 
additional 3-HPA was increased in this experiment, both S/N ratio and ion count of [miR-
124a + H
+
]
+
 ion were increased.  At the highest level (50%) of additional 3-HPA, the S/N 
ratio was increased more than 4 times in comparison to the conventional sample 
preparation method.  The significant increase on S/N ratio confirms that “spiking” the 
miR-124a sample with additional 3-HPA matrix before spotting on a thin-layer of dried  
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Figure 10. MALDI mass spectra of 5 µM miR-124a samples that were prepared by using the thin-layer 
method and different matrix compounds.  
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3-HPA matrix help to acquire stronger MALDI MS signals.  One of the key factors that 
caused an increase on the signals was due to the presence of additional ammonium citrate 
dibasic in the 3-HPA matrix, which further eliminated the sodium adducts of miR-124a 
and increased the signal of [miR-124a + H
+
]
+
 ion.  This was confirmed by the data 
obtained from adding 0 µM 3-HPA to 50 µM miR-124a sample, which yielded a S/N 
ratio of 45 (Table 7).  Based on the results in Table 7, the modified sample preparation 
method, which involves spiking a sample of interest with additional MALDI matrix 
before adding the mixture of matrix and sample on top of a spot of dried matrix, has a 
great potential to expand the current linear dynamic range for quantitation in MALDI 
mass spectrometry of different analytes. 
 
Table 7.  Summary of 3-HPA "spiking" study to optimize S/N  ratio
% 3-HPA matrix
[3-HPA matrix] Conc. Increase [miR-124a] S/N Resolution Count
125000 µM 3-HPA 50.0% 50 µM miR-124a 80 801 360
62500 µM 3-HPA 25.0% 50 µM miR-124a 55 876 194
31250 µM 3-HPA 12.5% 50 µM miR-124a 49 961 230
15625 µM 3-HPA 6.3% 50 µM miR-124a 41 915 152
7813 µM 3-HPA 3.1% 50 µM miR-124a 40 1003 164
3906 µM 3-HPA 1.6% 50 µM miR-124a 43 962 154
1953 µM 3-HPA 0.8% 50 µM miR-124a 44 953 186
125000 µM 3-HPA 50.0% 0 µM miR-124a - - -
0 µM 3-HPA 0.0% 50 µM miR-124a 45 1009 179
250000 µM 3-HPA - 50 µM miR-124a 17 927 68
miR-124a
 
Investigation of MALDI-TOF MS/MS parameters 
With the optimal parameters that have been determined to acquire maximum S/N 
ratio and ion count in the linear mode of MALDI-TOF MS, the focus of our efforts is 
shifted back to the MALDI-TOF MS/MS measurements of selected miRNA model.   
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Initially, the results from using the positive and negative ion mode to acquire the MS/MS 
spectra were compared.  As shown in Figure 11, the precursor ion of miR-124a was 
detected in the positive ion mode, and not detectable in the negative ion mode.  None of 
the expected CID fragments of miR-124a was detectable in both spectra.  Nevertheless, it 
was concluded the positive ion mode would be our choice to further the MS/MS 
experiments in this study. 
 
 
 
 
Figure 11. MS/MS spectra of [miR-124a + H
+
]
+
 at (a) positive and (b) negative ion mode.  20 µM miR-
124a was spotted on 3-HPA thin-layer matrix and analyzed using laser intensity = 7500 arb. units, CID 
pressure = 1.0e
-08
 Torr and delay time = 68321 ns.
a 
b 
In order to ensure there would be sufficient collisional gas to induce the 
fragmentation of miR-124a, the effects of different pressure of atmospheric air inside the 
collision cell were investigated.  An increase on the CID pressure may lead to additional 
collisions between air particles and miR-124a precursor ions, thus generating more CID 
fragments.  Referring to the results in Figure 12, low CID pressure at 1.0e
-07
 Torr and  
5.0e
-07 
Torr did not produce sufficient CID fragments for partial de novo sequencing.   
Whereas, with increasing CID pressures (≥1.0e
-06 
Torr), some of the CID fragments of 
miR-124a became detectable.  For more in-depth spectral interpretation of MS/MS 
spectra, please refer to the last section of this Chapter.  Overall, the increase on CID 
pressure did induce the fragmentation of miR-124a precursor ion (7,161 m/z) which 
would usually considered to be technically challenging for MALDI-TOF MS/MS. 
The manual setting of delay time for Source 2 in MALDI-TOF/TOF MS can be 
considered as a control for the duration of CID process before any fragment ions are 
extracted into the second TOF mass analyzer.  With longer the duration of CID process, 
there would have been more time to induce the fragmentation of precursor ion.  Owing to 
this reason, the effects of different duration of CID process (or delay time in Source 2) 
were investigated.  With delay time between 20,000 and 50,000 ns, only minimal CID 
fragments were detected as shown in Figure 13a.  These delay times might not provide 
sufficient time for the CID process to induce the fragmentation of selected precursor ion 
before any CID fragments were extracted from the CID cell or Source 2.  With delay time 
longer than 65,000 ns, similar MS/MS spectral patterns (Figure 13b) were observed as in 
the study of CID pressure.  The delay time of 68,000 ns is considered to the optimal delay 
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time for the fragmentation of miR-124a precursor ion.  This was partly because some of 
the remaining precursor ion was detected which was very useful for recalibrating the 
MS/MS spectrum. 
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Figure 12. MS/MS spectra of [miR-124a + H
+
]
+
 ion that were acquired at different CID pressure,  
1.0e
-07
 – 8.0e
-06
 Torr.  20 µM miR-124a was spotted on 3-HPA thin-layer matrix and analyzed using laser 
intensity = 7500 arb. units. 
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Figure 13. MS/MS spectra of [miR-124a + H
+
]
+
 that were acquired with low (a) and high (b) duration 
times for the CID process.  20 µM miR-124a was spotted on 3-HPA thin-layer matrix and analyzed using 
laser intensity = 7500 arb. units and CID pressure = 1.0e
-07 
Torr. 
 
After the extensive optimization of signal intensity of miR-124a precursor ion 
(laser intensity, concentration of miR-124s, sample preparation method, choice matrix 
compound and spiking of additional matrix), and the study of various parameters for 
carrying out MS/MS measurements of miR-124a (positive/negative ion mode, CID 
pressure and delay time), the production of CID fragments remained insufficient for 
partial de novo sequencing.  One of the possible explanations was the singly-charged 
[miR-124a + H
+
]
+
 precursor ion and some of its CID fragments (≥4,000 m/z) were too 
heavy for the current settings in the reflectron, which was an essential component in the 
instrument for MS/MS measurements.  As a result, the efficiency on channeling the ions 
a 
b 
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to the corresponding reflectron detector was significantly lowered.  To overcome this 
limitation from the reflectron, the doubly charged [miR-124a + 2H
+
]
2+
 ion with a mass-
to-charge ratio of 3,581 was used as an alternative precursor ion.  An advantage of using 
the doubly-charged precursor ion is the internal energy would be higher than that of the 
singly-charged ion.  In the MS/MS spectrum of doubly-charged [miR-124a + 2H
+
]
2+
 ion 
(Figure 14), the ion count of the precursor ion was greatly increased, and peaks that 
corresponded to some of the CID fragments could be easily detected. 
 
1553.4 2295.6
 
Figure 14. MS/MS spectrum of  [miR-124a + 2H
+
]
2+
 precursor ion and its fragment ions. 
 
Post-source decay (PSD) is an alternative approach to induce ion fragmentation.   
The PSD spectrum of [miR-124a + 2H
+
]
2+
 precursor ion was acquired (Figure 15).  The 
instrumental setup for PSD is exactly the same as MS/MS, except the collision cell is 
inactivated.  Therefore, the CID chamber is maintained at the same high vacuum (10e
-8
 
Torr) as in the rest of the MALDI-TOF MS instrument.  In the PSD mode, fragmentation 
of molecular ions occurs while the ions are traveling down the first TOF tube.  In 
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comparison of the PSD spectrum to the MS/MS spectrum (Figure 14), there is increase 
on signal intensity of most fragment ions, but the numbers of different fragment ions are 
lowered.  
 
 
Figure 15. MALDI mass spectrum of [miR-124a + 2H
+
]
2+
 ion that was acquired by using the mode of post-
source decay. 
 
Sequence analysis of miR-124a 
 Microsoft Office Excel was used to perform the calculations of theoretical 
molecular masses of CID fragments of miR-124a.  All expected CID fragments were 
generated according to the RNA sequence of miR-124a and the fragmentation pattern that 
has been reported (Figure 3).  Manually, the theoretical masses of expected CID fragment 
ions were compared with the measured masses.  Without the proper mass calibration, a 
mass error of ± 5 Da was acceptable at this early stage.  Based on the expected a/w ions, 
14% of the measured masses matched with the theorectical masses as shown in Table 8.   
Whereas, for the expected c/y ions, 31% matching was achieved (Table 9).  This 
complies with the report from Andersen et al., in which they had also observed c/y ions 
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as the most abundant fragment ions of 4-mer RNA.  As far as we are concerned, the 
above results represented the first attempt to fragment any miRNA that could contain as 
many as 25 nucleotides by using the high CID energy in MALDI-TOF/TOF MS.  Among 
the a/w and c/y ions, a total of 45% matching of measured masses with the theoretical 
masses was achieved, thus allowing some of the peaks in Figures 16 and 17 to be 
identified.  The other peaks in Figures 16 and 17 that have not been identified could 
correspond to other possible fragments, for example a-B ions or internal fragments.   
However, owing to the double charge on the precursor ion, the data interpretation has 
become very complex.  
 
Table 8. Identification of (a-w) fragment ions by comparing measured masses to theoretical masses of expected fragment ions
[miR-124a + 2H]
2+
Theoretical [miR-124a + 2H]
2+
Theoretical 
Fragment: Raw Spectra: a-Fragment: Fragment: Raw Spectra: w-Fragment:
a1 145.8873 154.5961 U 3581.7739 3581.1672 UUA AGG CAC GCG GUG AAU GCC A
a2 316.7495 307.6804 UU w1 3422.0947 3427.5789 UA AGG CAC GCG GUG AAU GCC A
a3 477.2531 472.2850 UUA w2 3303.0486 3274.4946 A AGG CAC GCG GUG AAU GCC A
a4 664.2319 636.8895 UUA A w3 3042.3982 3109.8900 AGG CAC GCG GUG AAU GCC A
a5 821.8332 809.4937 UUA AG w4 2903.7593 2945.2855 GG CAC GCG GUG AAU GCC A
a6 991.3998 982.0979 UUA AGG w5 2707.0781 2772.6813 G CAC GCG GUG AAU GCC A
a7 1146.5150 1134.6899 UUA AGG C w6 2561.4998 2600.0771 CAC GCG GUG AAU GCC A
a8 1288.2720 1299.2945 UUA AGG CA w7 2408.7510 2447.4851 AC GCG GUG AAU GCC A
a9 1463.2783 1451.8865 UUA AGG CAC w8 2293.0203 2282.8805 C GCG GUG AAU GCC A
a10 1658.3225 1624.4907 UUA AGG CAC G w9 2124.4348 2130.2885 GCG GUG AAU GCC A
a11 1767.8491 1777.0827 UUA AGG CAC GC w10 1938.1310 1957.6843 CG GUG AAU GCC A
a12 1938.1310 1949.6869 UUA AGG CAC GCG w11 1825.2515 1805.0923 G GUG AAU GCC A
a13 2124.4348 2122.2911 UUA AGG CAC GCG G w12 1658.3225 1632.4881 GUG AAU GCC A
a14 2293.0203 2275.3754 UUA AGG CAC GCG GU w13 1463.2783 1459.8839 UG AAU GCC A
a15 2408.7510 2447.9796 UUA AGG CAC GCG GUG w14 1288.2720 1306.7996 G AAU GCC A
a16 2561.4998 2612.5842 UUA AGG CAC GCG GUG A w15 1146.5150 1134.1954 AAU GCC A
a17 2707.0781 2777.1887 UUA AGG CAC GCG GUG AA w16 939.8189 969.5908 AU GCC A
a18 2903.7593 2930.2731 UUA AGG CAC GCG GUG AAU w17 821.8332 804.9863 U GCC A
a19 3042.3982 3102.8773 UUA AGG CAC GCG GUG AAU G w18 664.2319 651.9019 GCC A
a20 3303.0486 3255.4693 UUA AGG CAC GCG GUG AAU GC w19 477.2531 479.2977 CC A
a21 3422.0947 3408.0613 UUA AGG CAC GCG GUG AAU GCC w20 331.2343 326.7057 C A
3581.7739 3581.1672 UUA AGG CAC GCG GUG AAU GCC A w21 175.0853 174.1137 A
5'-Phos to 3'-OH miR-124a Fragment Sequence5'-Phos to 3'-OH miR-124a Fragment Sequence
4
9
 
 
Figure 16. MS/MS spectra of [miR-124a + 2H
+
]
2+
 precursor ion, with selected (a-w) fragment ions being highlighted.  Refer to Table 8 to identify 
fragment sequence and m/z ratio for each a- and w- fragment. 
5
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Table 9. Identification of (c-y) fragment ions by comparing measured masses to theoretical masses of expected fragment ions
[miR-124a + 2H]
2+
Theoretical [miR-124a + 2H]
2+
Theoretical 
Fragment: Raw Spectra: c-Fragment: Fragment: Raw Spectra: y-Fragment:
c1 192.6126 194.5793 U 3581.7739 3581.1672 UUA AGG CAC GCG GUG AAU GCC A
c2 351.5266 347.6636 UU y1 3370.8938 3387.5958 UA AGG CAC GCG GUG AAU GCC A
c3 513.7394 512.2682 UUA y2 3303.0486 3234.5114 A AGG CAC GCG GUG AAU GCC A
c4 682.0699 676.8727 UUA A y3 3042.3982 3069.9069 AGG CAC GCG GUG AAU GCC A
c5 863.1318 849.4769 UUA AG y4 2903.7593 2905.3023 GG CAC GCG GUG AAU GCC A
c6 1023.9087 1022.0811 UUA AGG y5 2707.0781 2732.6981 G CAC GCG GUG AAU GCC A
c7 1146.5150 1174.6731 UUA AGG C y6 2561.4998 2560.0939 CAC GCG GUG AAU GCC A
c8 1360.6445 1339.2777 UUA AGG CA y7 2408.7510 2407.5019 AC GCG GUG AAU GCC A
c9 1463.2783 1491.8697 UUA AGG CAC y8 2293.0203 2242.8974 C GCG GUG AAU GCC A
c10 1658.3225 1664.4739 UUA AGG CAC G y9 2075.6077 2090.3054 GCG GUG AAU GCC A
c11 1825.2515 1817.0659 UUA AGG CAC GC y10 1936.6866 1917.7012 CG GUG AAU GCC A
c12 1938.1310 1989.6701 UUA AGG CAC GCG y11 1767.8491 1765.1092 G GUG AAU GCC A
c13 2179.9497 2162.2743 UUA AGG CAC GCG G y12 1658.3225 1592.5050 GUG AAU GCC A
c14 2293.0203 2315.3586 UUA AGG CAC GCG GU y13 1401.4368 1419.9008 UG AAU GCC A
c15 2408.7510 2487.9628 UUA AGG CAC GCG GUG y14 1288.2720 1266.8164 G AAU GCC A
c16 2707.0781 2652.5674 UUA AGG CAC GCG GUG A y15 1048.7485 1094.2122 AAU GCC A
c17 2903.7593 2817.1719 UUA AGG CAC GCG GUG AA y16 926.0856 929.6077 AU GCC A
c18 2903.7593 2970.2563 UUA AGG CAC GCG GUG AAU y17 784.1602 765.0031 U GCC A
c19 3042.3982 3142.8605 UUA AGG CAC GCG GUG AAU G y18 609.7697 611.9188 GCC A
c20 3303.0486 3295.4525 UUA AGG CAC GCG GUG AAU GC y19 447.6925 439.3146 CC A
c21 3458.0552 3448.0445 UUA AGG CAC GCG GUG AAU GCC y20 291.6314 286.7226 C A
3581.7739 3581.1672 UUA AGG CAC GCG GUG AAU GCC A y21 133.8575 134.1306 A
5'-Phos to 3'-OH miR-124a Fragment Sequence5'-Phos to 3'-OH miR-124a Fragment Sequence
5
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Figure 17. MS/MS spectra of [miR-124a + 2H
+
]
2+
 precursor ion, with selected (c-y) fragment ions being highlighted.  Refer to Table 9 to identify 
fragment sequence and m/z ratio for each c- and y- fragment. 
5
2
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CHAPTER IV 
CONCLUSIONS 
 The studies of MALDI-TOF MS in the linear positive ion mode through the 
investigation of the effects of laser intensity on 3-HPA matrix and miR-124a, 
concentration of miR-124a, sample preparation methods and using five different MALDI 
matrix compounds have provided our research group with a great deal of information and 
understanding on the desorption process of MALDI.  These provided our research group 
and the others within the scientific community a good foundation towards the clinical 
applications of MALDI-TOF MS in miRNA analysis.  In addition, the knowledge 
generated in this thesis is easily applicable to the analysis of other small non-coding RNA 
molecules. 
 Specifically, optimal parameters for linear MALDI-TOF MS and sample 
preparation method have been determined for miRNA analysis.  The comparison study of 
five different MALDI matrices has demonstrated a correlation between the characteristics 
of matrix compound and the success of MALDI-TOF MS measurements.  The hydro- 
phobicity study showed that as matrix compound increased on its molecular mass which 
is proportional to the hydrophobicity of the matrix compound.  Therefore, small matrix 
compound would provide less hydrophobic interactions with each other as compared to 
larger matrix compounds.  50% DMF was confirmed to be the best solvent for for 
solubilizing the selected matrix compounds and attained sufficiently high molar 
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concentration to support the MALDI process.  3-HPA matrix allowed for the fastest 
sample preparation due to having the fastest drying time, compared to the other four 
matrix compounds.  UV absorbance measurements confirmed that DABP has the highest 
absorptivity at 355 nm.  When the results of MALDI-TOF MS measurements were 
compared, 3-HPA yielded the highest S/N ratio and ion count.  The overall comparison 
study allowed for a better understanding of how the size and structure of a matrix 
compound could affect the outcome of MALDI-TOF MS analysis.  
 The [miR-124a + 2H
+
]
2+
 precursor ion provided the best MS/MS spectra for miR-
124a sequence analysis.  Since the RNA sequence of miR-124a is known and validated, 
Microsoft Office Excel can therefore be used to calculate the theoretical masses of 
expected CID fragment ion of miR-124a.  The peaks in the MS/MS spectra of either 
[miRNA + H
+
]
+
 and [miRNA + 2H
+
]
2+
 precursor ion could be identified by comparing 
the measured masses with the theoretical masses, thus allowing partial de novo 
sequencing of miR-124a.  However, the MS/MS process still needs to be studied further 
due to the fact that spectral data seems to be irreproducible.  The acquisition of two 
MS/MS spectra might never be the results of exactly the same fragmentation pattern due 
to the nature of the CID process itself. 
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